Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Accounts Payable
Dexcom Inc
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Accounts Payable
$269.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
24%
|
CAGR 10-Years
50%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$921m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$194.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is Dexcom Inc's Accounts Payable?
Accounts Payable
269.7m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Accounts Payable amounts to 269.7m USD.
What is Dexcom Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
50%
Over the last year, the Accounts Payable growth was 1%. The average annual Accounts Payable growth rates for Dexcom Inc have been 21% over the past three years , 24% over the past five years , and 50% over the past ten years .